| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.89B | $2.92B | $2.72B |
| YoY Revenue Growth % | -1.3% | +7.4% | — |
| Gross Profit | $472.6M | $524.3M | — |
| Gross Margin % | 16.4% | 17.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $168.5M | $232.8M | $222.0M |
| Operating Margin % | 5.8% | 8.0% | 8.2% |
| Net Income (GAAP) | $32.6K | $95.0K | $119.6K |
| EBITDA (Normalized) | $207.5M | $282.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $129.1M | $327.0M | -$74.6M |
| Capital Expenditures (CapEx) | $48.8M | $62.6M | — |
| Free Cash Flow (FCF) | $80.3M | $264.4M | -$74.6M |
| FCF Margin % | 2.8% | 9.0% | -2.7% |
| Return on Invested Capital (ROIC %) | 6.6% | 9.9% | — |
| Cash & Short-Term Equivalents | $85.2M | $215.1M | — |
| Total Debt (Short + Long Term) | $616.6M | $617.8M | — |
| Total Stockholders' Equity | $1.48B | $1.45B | — |